Effect of a novel phosphodiesterase type 5 inhibitor, CPD1, on paraquat-induced lung fibrosis in rats

Jie GAO; Jian WU; Jie GAO; Jing ZHANG; Jian WU; Jian-Qin YANG; Hao-Heng QIU; Zi-Jian ZHAO; Fang-Hong LI; Yun-Ping MU.
Chinese Pharmacological Bulletin ; (12): 1136-1142, 2023.
Artículo en Zh | WPRIM | ID: wpr-1013901

Documentos relacionados

  1. [Paraquat-induced acute dermatitis in a child after playing with a discarded container].
  2. Study of paraquat-induced pulmonary fibrosis using biomimetic micro-lung chips.
  3. [Effect of a novel phosphodiesterase 5 inhibitor, CPD1, on renal interstitial fibrosis after unilateral renal ischemia-reperfusion injury].
  4. [Effects of Nintedanib associated with Shenfu Injection on paraquat-induced lung injury in rats].
  5. [Effect of pirfenidone on paraquat-induced pulmonary fibrosis in rats].
  6. [Effect of bone marrow mesenchymal stem cells on paraquat-induced pulmonary fibrosis in rats].
  7. Discovery of a pyrano[2,3-b]pyridine derivative YX-2102 as a cannabinoid receptor 2 agonist for alleviating lung fibrosis.
  8. [The roles of TSP-1 and its receptor CD47 in pathogenesis of paraquat-induced pulmonary fibrosis in rats].
  9. The novel peptide DR4penA attenuates the bleomycin- and paraquat-induced pulmonary fibrosis by suppressing the TGF-ß/Smad signaling pathway.
  10. Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2/ERK/p38 axis.